Citadel Advisors’s Can-Fite BioPharma CANF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,171
| Closed | -$31.5K | – | 5980 |
|
|
2024
Q1 | $31.5K | Buy |
+14,171
| New | +$31.5K | ﹤0.01% | 5444 |
|
|
2022
Q2 | – | Sell |
-1,133
| Closed | -$14K | – | 6066 |
|
|
2022
Q1 | $14K | Buy |
+1,133
| New | +$14K | ﹤0.01% | 6180 |
|
|
2021
Q3 | – | Sell |
-3,862
| Closed | -$88K | – | 6420 |
|
|
2021
Q2 | $88K | Sell |
3,862
-2,146
| -36% | -$48.9K | ﹤0.01% | 6020 |
|
|
2021
Q1 | $148K | Buy |
+6,008
| New | +$148K | ﹤0.01% | 5609 |
|
|
2020
Q4 | – | Sell |
-1,187
| Closed | -$21K | – | 5092 |
|
|
2020
Q3 | $21K | Buy |
+1,187
| New | +$21K | ﹤0.01% | 4517 |
|
|
2020
Q2 | – | Sell |
-2,013
| Closed | -$26K | – | 4675 |
|
|
2020
Q1 | $26K | Buy |
+2,013
| New | +$26K | ﹤0.01% | 4628 |
|
|
2019
Q4 | – | Sell |
-2,316
| Closed | -$48K | – | 4649 |
|
|
2019
Q3 | $48K | Buy |
+2,316
| New | +$48K | ﹤0.01% | 4366 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4308 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4191 |
|
|
2017
Q4 | – | Sell |
-78
| Closed | -$20K | – | 3890 |
|
|
2017
Q3 | $20K | Sell |
78
-34
| -30% | -$8.72K | ﹤0.01% | 3519 |
|
|
2017
Q2 | $30K | Buy |
+112
| New | +$30K | ﹤0.01% | 3447 |
|
|
2017
Q1 | – | Sell |
-95
| Closed | -$34K | – | 3674 |
|
|
2016
Q4 | $34K | Buy |
+95
| New | +$34K | ﹤0.01% | 3366 |
|
|
2015
Q2 | – | Sell |
-70
| Closed | -$23K | – | 3813 |
|
|
2015
Q1 | $23K | Buy |
+70
| New | +$23K | ﹤0.01% | 3504 |
|